(Fighting against New Coronary Pneumonia) China has lowered the cost of nucleic acid testing for new coronaviruses to no more than 16 yuan for a single person and a single test
China News Agency, Beijing, May 25th. The Office of the National Medical Security Administration of China and the Medical Rescue Team of the Joint Prevention and Control Mechanism of the State Council recently issued a notice, requiring all localities to reduce the single-person nucleic acid test for the new coronavirus to no more than every single person before June 10. 16 yuan per person (RMB, the same below), and multi-person mixed inspection is reduced to no more than 5 yuan per person.
The notice clarifies that the government-guided prices for new coronavirus nucleic acid tests and antigen tests formulated by various provinces are all price ceilings, and the actual charging standards of public medical institutions cannot go up or down.
For the large-scale screening and normalized testing of government organizations, the scale effect and the cost-sharing effect of grassroots organizations and volunteers must be fully considered. The multi-person mixed testing of new coronavirus nucleic acid shall be calculated according to the standard of no more than 3.5 yuan per person. If the testing institution only provides sample transfer and testing services, the billing standard needs to be further reduced.
The notice pointed out that the new coronavirus antigen testing services carried out by public medical institutions are charged according to the method of "price items + testing reagents".
Among them, the government-guided price of the "new crown antigen detection" medical service price item has been reduced to no more than 2 yuan per person; the new crown antigen detection reagents (including sampling equipment) are sold according to the actual purchase price zero markup; "price items + detection reagents" "The capping standard of the total amount of charges is reduced to no more than 6 yuan per person.
The notice also emphasized that public medical institutions should provide both single-person single-check and multi-person mixed-check service options when conducting nucleic acid testing services for the new coronavirus. voluntary choice.
Non-public medical institutions and social testing institutions such as medical testing laboratories provide new coronavirus nucleic acid testing services, and the pricing should follow the principles of "fairness, legality, and good faith", reflecting the preservation of low profits and consistent quality and price. It is advisable to refer to the price of new crown nucleic acid testing in local public medical institutions.
The National Medical Insurance Administration pointed out that the nucleic acid detection of the new coronavirus is an important means of normalizing the epidemic prevention and control. Medical insurance departments at all levels proceed from the overall situation of coordinating epidemic prevention and control and economic and social development, adopting centralized procurement through inter-provincial alliances, bidding on the Internet, and regional price linkage. The majority of public medical institutions and social testing institutions continue to optimize the work efficiency of each link of procurement, transportation, and inspection, and collaborate to promote a reasonable reduction in the price of nucleic acid testing.
(Finish)